The ESG develops a free of charge online updating program for women’s health HCPs.
Each month 2 keynote speakers will discuss on a range of topics devoted to improving your knowledge and professional development in your daily clinical practice.
Additionally, you will have the opportunity to participate in live question and answer sessions.These monthly resources provide you with invaluable and engaging insights covering a wide spectrum of subjects, including Breast Cancer, IVF, Pregnancy, Hypotalamic Amenorrhea, Gynecologial Oncology, Genital Infections and many others.
To access the library of on-demand webinars available anytime, please click on “Past webinars”.


Gynecology & Obstetrics

2 speakers each month

Time for Q&A
UPCOMING WEBINARS
PAST WEBINARS
UPCOMING WEBINARS
PAST WEBINARS
Prof. Andrea R. Genazzani
Chairman

Prof. Tommaso Simoncini
Vasomotor Symptoms: a marker of postmenopausal risks

Prof. Herman Depypere
NKR antagonists for vasomotor symptoms treatment

Prof. Andrea R. Genazzani
Chairman

Prof. Michelle Nisolle
New insights of Physiopathology of Menorragia

Prof. Natalia Pedachenko
Overcoming the challenges in fertility sparing management of myomas

New Advances in the Pathophysiology and Medical Treatments of Endometriosis
26-Mar-2024 15:00–16:30
Prof. Andrea R. Genazzani
Chairman

Prof. Stefano Angioni
Advances in Physiopathology

Prof. Geraldine Brinchant
Which medical treatment?

Prof. Andrea R. Genazzani
Chairman

Dr. Fernanda Santos

Dr. Damian Dexeus

Eduard Mension
Menopause in Breast Cancer Survivors

Camil Castelo Branco
Sexuality and sexual dysfunction: more that GSM

Yves Ville
For

Gerard Visser
Against

Blazej Meczekalski
Stress, Kisspeptin and Functional Hypothalamic Amenorrhea

Alessandro Genazzani
Integrative approach to Functional Hypothalamic Amenorrhea and the use of low dose estrogens

Andrzej Milewicz
Adolescence, reproductive period of life and pregnancy

Andrea Genazzani
From climacterium to old age

Johannes Ott
Progestogens in Luteal phase supplementation

Alfred Mueck
The choice of progestogen for HRT
